Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132337) titled 'Study on the Value of PSMA PET/MR in the Precise Diagnosis and Treatment of Prostate Cancer Radical Surgery' on Sept. 12.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Prostate cancer
Intervention:
Gold Standard:Pathological results of the surgical specimen
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-05
Target Sample Size: Target condition:100;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=330381
Disclaimer: Curated...